Banque Pictet & Cie’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,350
Closed -$258K 446
2025
Q4
$258K Hold
10,350
﹤0.01% 384
2025
Q3
$264K Hold
10,350
﹤0.01% 376
2025
Q2
$251K Hold
10,350
﹤0.01% 346
2025
Q1
$262K Sell
10,350
-4,758
-31% -$125K ﹤0.01% 367
2024
Q4
$401K Buy
15,108
+1,318
+10% +$35.8K ﹤0.01% 298
2024
Q3
$399K Buy
13,790
+3,354
+32% +$97.8K ﹤0.01% 275
2024
Q2
$292K Buy
10,436
+86
+0.8% +$2.37K ﹤0.01% 281
2024
Q1
$287K Hold
10,350
﹤0.01% 297
2023
Q4
$298K Sell
10,350
-368,703
-97% -$11.1M ﹤0.01% 310
2023
Q3
$12.6M Buy
379,053
+74,281
+24% +$2.63M 0.15% 72
2023
Q2
$11.2M Buy
304,772
+75,789
+33% +$2.95M 0.1% 102
2023
Q1
$9.34M Sell
228,983
-17,349
-7% -$749K 0.09% 109
2022
Q4
$12.6M Sell
246,332
-37,967
-13% -$1.82M 0.13% 86
2022
Q3
$12.4M Buy
284,299
+106,763
+60% +$5.19M 0.14% 87
2022
Q2
$9.31K Sell
177,536
-75,486
-30% -$3.85M 0.09% 102
2022
Q1
$13.1M Buy
253,022
+13,970
+6% +$725K 0.1% 94
2021
Q4
$14.1M Buy
239,052
+3,420
+1% +$169K 0.1% 100
2021
Q3
$10.1M Buy
235,632
+32,505
+16% +$1.44M 0.11% 91
2021
Q2
$7.95M Sell
203,127
-3,893
-2% -$151K 0.09% 108
2021
Q1
$7.5M Sell
207,020
-21,473
-9% -$762K 0.1% 110
2020
Q4
$8.41M Sell
228,493
-37,655
-14% -$1.38M 0.11% 94
2020
Q3
$9.27M Sell
266,148
-29,975
-10% -$1.05M 0.14% 84
2020
Q2
$9.19M Buy
296,123
+28,245
+11% +$960K 0.15% 77
2020
Q1
$8.3M Sell
267,878
-36,415
-12% -$1.24M 0.17% 73
2019
Q4
$11.3M Sell
304,293
-22,355
-7% -$796K 0.2% 74
2019
Q3
$11.1M Buy
326,648
+122,852
+60% +$4.47M 0.21% 68
2019
Q2
$8.38M Buy
203,796
+40,276
+25% +$1.6M 0.15% 85
2019
Q1
$6.59M Sell
163,520
-7,275
-4% -$291K 0.13% 111
2018
Q4
$7.07M Sell
170,795
-19,131
-10% -$794K 0.14% 100
2018
Q3
$7.94M Buy
189,926
+27
+0% +$1.04K 0.15% 104
2018
Q2
$6.54M Buy
189,899
+7,367
+4% +$252K 0.13% 128
2018
Q1
$6.15M Buy
182,532
+60,394
+49% +$2.08M 0.13% 128
2017
Q4
$4.2M Buy
122,138
+21,899
+22% +$747K 0.08% 151
2017
Q3
$3.4M Buy
100,239
+3,268
+3% +$105K 0.08% 165
2017
Q2
$3.09M Sell
96,971
-31,770
-25% -$1M 0.07% 167
2017
Q1
$4.18M Buy
128,741
+61,725
+92% +$1.95M 0.1% 139
2016
Q4
$2.06M Sell
67,016
-25,328
-27% -$773K 0.05% 182
2016
Q3
$2.97M Sell
92,344
-7,212
-7% -$241K 0.08% 146
2016
Q2
$3.33M Sell
99,556
-17,688
-15% -$565K 0.09% 139
2016
Q1
$3.3M Buy
117,244
+17,119
+17% +$489K 0.09% 137
2015
Q4
$3.07M Sell
100,125
-35,758
-26% -$1.12M 0.08% 137
2015
Q3
$4.05M Buy
+135,883
New +$4.36M 0.12% 124
2015
Q2
Sell
-179,102
Closed -$5.91M 443
2015
Q1
$5.91M Buy
179,102
+18,874
+12% +$600K 0.15% 125
2014
Q4
$4.74M Buy
160,228
+24,652
+18% +$707K 0.12% 136
2014
Q3
$3.8M Sell
135,576
-4,911
-3% -$138K 0.1% 147
2014
Q2
$3.96M Sell
140,487
-2,315
-2% -$66K 0.1% 145
2014
Q1
$4.35M Sell
142,802
-131,778
-48% -$3.93M 0.12% 129
2013
Q4
$7.98M Buy
+274,580
New +$7.99M 0.24% 76

Other funds holding PFE

Banque Pictet & Cie's PFE Position: Q1 2026 in Review

Banque Pictet & Cie sold out of Pfizer (PFE) in Q1 2026, closing a stake of 10,350 shares — an estimated $258K sold.

Banque Pictet & Cie first reported a position in PFE in Q4 2013 and held it in 48 quarters. The position peaked at $14.1M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Banque Pictet & Cie reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Banque Pictet & Cie sold 10,350 Pfizer shares in Q1 2026, an estimated $258K.
  • Banque Pictet & Cie first reported a position in Pfizer in Q4 2013 and held it in 48 quarters.
  • Banque Pictet & Cie's Pfizer position peaked at $14.1M in Q4 2021.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Banque Pictet & Cie's 13F filing for Q1 2026, filed 14 Apr 2026.